Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):506–513. doi: 10.1097/00126334-200304150-00007

FIG. 1.

FIG. 1

Trial profile: *371 HIV-uninfected women in the universal arm were followed in the study, but their cord blood was not assayed for NVP, and they are not reported on here. †Composite adherence outcome includes those from whom cord blood specimens were available plus those who returned their NVP tablet plus (in the targeted group only) and two patients from whom cord blood specimens were missing but in whom NVP ingestion was directly observed by study staff.